Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
LLY Coverage
Event
Eli Lilly and Company (LLY) Q1 2026 Earnings Call
Apr 16, 2026
Event
Eli Lilly and Company (LLY) Q1 2026 Earnings Announcement
Apr 16, 2026
Event
Eli Lilly and Company (LLY) ACHIEVE-4, the longest Phase 3 study of Lilly’s Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
Apr 16, 2026
Transcript
Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript
Mar 10, 2026
News
Eli Lilly and Company (LLY) Surges 5.1% — Developing Story
Feb 23, 2026
News
Eli Lilly and Company (LLY) to acquire Orna Therapeutics
Feb 9, 2026
News
Key highlights from Eli Lilly’s (LLY) Q4 2025 earnings results
Feb 4, 2026
Transcript
Eli Lilly and Company (LLY) Q2 2025 Earnings Call Transcript
Jan 22, 2026